Müller H P, Heinecke A, Borneff M, Kiencke C, Knopf A, Pohl S
Department of Operative Dentistry and Periodontology, University of Heidelberg, Germany.
J Periodontal Res. 1998 Jan;33(1):49-58. doi: 10.1111/j.1600-0765.1998.tb02291.x.
Eradication of Actinobacillus actinomycetemcomitans from the oral cavity seems to be a prerequisite for successful therapeutic outcome in patients periodontally infected with the organism. In view of the limited number of subgingival samples obtained in recent studies one cannot conclude, however, whether eradication has actually been achieved. In the present study clinical and microbiological parameters were monitored in 10 adult patients with A. actinomycetemcomitans-associated periodontitis during successive non-surgical and adjunctive metronidazole plus amoxicillin (or ciprofloxacin) (AB) therapy. In every patient, 13 extracrevicular samples and subgingival samples from the deepest site of every tooth present were selectively cultivated for A. actinomycetemcomitans. The organism was isolated in 47 +/- 29% subgingival and 64 +/- 31% extracrevicular samples. Six weeks following subgingival scaling, A. actinomycetemcomitans was detected in 37 +/- 30% subgingival and 55 +/- 38% extracrevicular samples (n.s.). Three months after antibiotic therapy, the organism was recovered from only 1 patient. At baseline, 7.5 +/- 4.2% sites had a probing pocket depth (PPD) > or = 7 mm. This proportion dropped to 2.3 +/- 2.4% after scaling (p < 0.05) and to 0.3 +/- 0.4% after AB (p < 0.05). The proportion of sites with clinical attachment loss (CAL) > or = 6 mm dropped from 23.3 +/- 13.3% to 17.7 +/- 13.4% (p < 0.05) and to 16.8 +/- 14.6%. Statistical analysis revealed that the organism was strongly related, at baseline, to PPD > or = 7 mm (odds ratio 9.8, p < 0.001). Six weeks after scaling, the organism was associated with CAL > or = 6 mm (odds ratio 1.8, p = 0.02). After scaling, high counts of A. actinomycetemcomitans in excess of 10(4) CFU/ml significantly interfered with attachment gain of > or = 2 mm (odds ratio 0.24, p = 0.001). Based on the present findings, eradication of A. actinomycetemcomitans seems to be possible with adjunctive antibiotic treatment. Elimination of the organism after scaling was only weakly associated with clinical improvement.
从口腔中根除伴放线放线杆菌似乎是牙周感染该菌的患者获得成功治疗结果的前提条件。然而,鉴于近期研究中获取的龈下样本数量有限,无法得出是否真的实现了根除的结论。在本研究中,对10例患有伴放线放线杆菌相关性牙周炎的成年患者在连续进行非手术治疗以及辅助使用甲硝唑加阿莫西林(或环丙沙星)(AB)治疗期间的临床和微生物学参数进行了监测。对每位患者,从每颗牙最深部位采集的13份龈上样本和龈下样本进行了伴放线放线杆菌的选择性培养。该菌在47±29%的龈下样本和64±31%的龈上样本中被分离出来。龈下刮治六周后,在37±30%的龈下样本和55±38%的龈上样本中检测到伴放线放线杆菌(无统计学差异)。抗生素治疗三个月后,仅从1例患者中分离出该菌。基线时,7.5±4.2%的位点探诊深度(PPD)≥7mm。刮治后该比例降至2.3±2.4%(p<0.05),AB治疗后降至0.3±0.4%(p<0.05)。临床附着丧失(CAL)≥6mm的位点比例从23.3±13.3%降至17.7±13.4%(p<0.05),并降至16.8±14.6%。统计分析显示,在基线时,该菌与PPD≥7mm密切相关(优势比9.8,p<0.001)。刮治六周后,该菌与CAL≥6mm相关(优势比1.8,p = 0.02)。刮治后,伴放线放线杆菌计数超过10⁴CFU/ml显著干扰了≥2mm的附着获得(优势比0.24,p = 0.001)。基于目前的研究结果,辅助使用抗生素治疗似乎有可能根除伴放线放线杆菌。刮治后该菌的清除与临床改善仅呈弱相关。